RE:RE:RE:RE:RE:RE:RE:The company and only the companyGood for you Lee! I'm still hiding everything from my wife. I wouldn't sell at $2bil, that's peanuts if either program works out. I don't think Paul would either. He's young and has a rare chance to make his company into something quite large if he let's it all play out. I also think the developments will happen so quickly if they are positive that the market cap will figure out the revenue potential and be well beyond that level if SORT1 is a reality or NASH is.
Lee430 wrote: Wasn’t is mentioned here some time ago that someone in Greenspoon’s research group was also collaborating with Pfizer on a project and that Pfizer was most likely aware of the NASH research, was thinking Pfizer should have some fresh capitol from the Covid vaccine profits that would be needing a home and Thera sure would be an attractive place to park it right now…..SP of $200 sounds exciting but honestly I know it would be leaving a lot on the table, however, an offer of $25 would get my vote, that’s only $2B for the whole company so a SP of $200 doesn’t really sound all that crazy.
Wino, I did take your advice on that older post and moved a large percentage of my 401K into Thera, although I did not hide this from my wife let’s just say the info was not offered up until the SP started to rally a bit ;->